NCT04092517

Brief Summary

Lack of adequate nutrition is the single biggest contributor to child mortality. Malawi is amongst the countries most affected. In global feeding programmes several variations of fortified blended foods are used and imported into the country of need as supplementary foods. However, the accessibility and efficacy of supplementary feeding is variable and can be a limiting factor for success in preventing and treating malnutrition. Therefore, in countries with widespread hunger, an increasing demand exists for innovative strategies offering alternative solutions for year-round access to commonly consumed home-grown products with good nutritional value. Moringa Oleifera - described as 'a nutritional and medicinal cornucopia' is common throughout in Malawi. Moringa leaves can be repeatedly cropped and are rich source of nutrients and non-nutrient bioactive compounds. These nutritional characteristics give Moringa the potential to significantly contribute in Malawi's battle against malnutrition and mineral element deficiencies. The aim of this study is to compare Moringa as a substitute in specially formulated supplementary foods in order to evaluate the in vivo bioavailability of key nutrients and bioactives and biological activities of the plant. This would assess the potential for establishing Moringa oleifera as an economically viable crop which could contribute towards establishing a resilient food supply chain in Malawi that will deliver essential nutrients across the population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 13, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 15, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2019

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2019

Completed
6 months until next milestone

First Posted

Study publicly available on registry

September 17, 2019

Completed
Last Updated

September 17, 2019

Status Verified

September 1, 2019

Enrollment Period

7 months

First QC Date

October 15, 2018

Last Update Submit

September 16, 2019

Conditions

Keywords

phytochemicalssystemic circulation

Outcome Measures

Primary Outcomes (1)

  • Change in concentration of phytochemical metabolites in the systemic circulation

    Difference in concentration of phytochemical metabolites between baseline and postprandial states

    up to 24 hours

Study Arms (2)

Control Corn Soya Diet

ACTIVE COMPARATOR

Control Corn Soya Diet will be prepared to a formulation for Corn Soya Blend (SUPER CEREAL) product adopted by the WFP as complementary food for children over than 6 months.

Other: Control Corn Soya Diet

Test Corn Moringa Diet

EXPERIMENTAL

Test Corn Moringa Diet will be prepared to the same formulation as Corn Soya Blend, but the Soya content will be replaced with Moringa and no micronutrient premix will be added.

Other: Test Corn Moringa Diet

Interventions

Ingredients (% by weight): Maize (78.30); Whole soya beans (20.00); Vitamin/Mineral FBF-V-13 (0.20); Dicalcium Phosphate anhydrous (1.23); Potassium chloride (0.27)

Control Corn Soya Diet

Ingredients (% by weight): Maize (78.30); Moringa (20.0)

Test Corn Moringa Diet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy males or females;
  • BMI 18-35;
  • Age 18+

You may not qualify if:

  • Subjects are taking prescribed medication;
  • Subjects are pregnant or breastfeeding;
  • Have given a blood donation in the last three months;
  • Are unable to give written informed consent;
  • Have eating disorders such as anorexia, bulimia, binge eating or night eating syndrome;
  • Report any significant health issue;
  • Subjects are taking vitamin or mineral supplements (unless they agree to discontinue supplementation 2wk before the start of the study);
  • Food allergies/intolerances.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Aberdeen

Aberdeen, AB25 2ZD, United Kingdom

Location

MeSH Terms

Conditions

Malnutrition

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Wendy Russell, PhD

    University of Aberdeen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 15, 2018

First Posted

September 17, 2019

Study Start

September 13, 2018

Primary Completion

March 30, 2019

Study Completion

March 31, 2019

Last Updated

September 17, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations